A peer-reviewed, open-access journal for immunological research into allergic disease and hypersensitivity — from mast cell and IgE biology to allergen structure and immune biomarkers.
What IJA is
The International Journal of Allergy (IJA) publishes original research, reviews, and short communications on the immunological mechanisms of allergy and hypersensitivity. It is written for immunologists, allergists, and translational scientists studying how the immune system drives allergic inflammation at the cellular, antibody, and molecular level.
IJA is deliberately mechanistic. It prioritises work that explains how hypersensitivity arises — immune-cell behaviour, antibody responses, receptor and cytokine signalling, allergen immunology, and biomarkers — rather than clinical management or drug-efficacy trials. Every accepted article is published open access under CC BY 4.0 and receives a Crossref DOI.
Journal at a glance
- Access model
- Open access, immediate
- Licence
- CC BY 4.0 · authors retain copyright
- Peer review
- Single-blind · two or more independent reviewers
- First decision
- About 21 days from submission
- Article-processing charge
- US$1,200 (US$540 for students) · on acceptance only
- Article identifier
- A Crossref DOI on every article
- Discoverability
- Google Scholar and OpenAlex
- Editorial board
- 9 members across 9 countries
- Publication ethics
- COPE-aligned
What IJA publishes
IJA maintains a disciplined focus on the immunological mechanisms of allergy — the molecular, cellular, and systemic processes that produce hypersensitivity.
Immune cell biology
Mast cell degranulation, basophil and eosinophil function, Th1/Th2 balance, regulatory T cells, and dendritic-cell antigen presentation.
Antibody & immunoglobulin biology
IgE synthesis and regulation, IgG4 responses, B-cell activation, and humoral immunity in hypersensitivity.
Hypersensitivity mechanisms
Type I–IV pathways, complement activation, immune-complex formation, and cytokine-driven inflammation.
Immunological signalling
FcεRI receptor signalling, IL-4/IL-5/IL-13 networks, chemokine-mediated recruitment, and JAK–STAT pathways.
Allergen immunology
Allergen structure and immunogenicity, epitope mapping, cross-reactivity, and allergen processing and presentation.
Immune biomarkers
Discovery and validation of biomarkers for sensitisation and disease mechanism, and immune-profiling methods.
In scope
- Mechanistic studies of immune-cell behaviour and antibody responses
- Receptor, cytokine, and signalling pathway analysis
- Allergen biochemistry and immunological models
- Biomarker discovery and immunogenetics
Out of scope
- Clinical case reports, treatment protocols, and diagnostic guidelines
- Patient-management strategies and immunotherapy-administration studies
- Epidemiological surveys and public-health studies
- Non-immunological disease mechanisms
Editorial board
IJA is guided by an international editorial board of nine researchers in allergy and clinical immunology, spanning nine countries. Board members assess manuscripts within their areas of expertise and uphold the journal’s editorial standards.
How publication works
- 1SubmitUpload your manuscript through the online submission system.
- 2Editorial screeningThe editorial office checks scope fit and completeness within 2–3 business days.
- 3Peer reviewSingle-blind review by two or more independent experts.
- 4DecisionA first editorial decision within about 21 days of submission.
- 5RevisionPoint-by-point response; revised manuscripts are re-assessed promptly.
- 6PublicationAccepted articles are copyedited, assigned a Crossref DOI, and published open access.
Free to submit and to be reviewed — the article-processing charge applies only after acceptance.
What every IJA article receives
- ✓A registered Crossref DOI for every article
- ✓Immediate open access under CC BY 4.0 — you keep the copyright
- ✓Discoverability through Google Scholar and OpenAlex
- ✓Single-blind peer review by two or more independent experts
- ✓Editorial handling aligned with COPE guidelines
- ✓Professional copyediting before publication
Ethics & research integrity
IJA follows the Committee on Publication Ethics (COPE) principles and international reporting standards:
- Human-subjects research requires ethics-committee approval, informed consent, and adherence to the Declaration of Helsinki.
- Animal research requires IACUC (or equivalent) approval and ARRIVE-compliant reporting.
- All authors disclose funding sources and competing interests.
- Data must be original and available; image manipulation is prohibited.
- Authorship follows ICMJE criteria, and any use of AI tools must be disclosed.
Article types
Original Research
Novel immunological investigations using experimental, cellular, molecular, or model systems.
Review Articles
Critical syntheses of a specific immunological mechanism that identify clear knowledge gaps.
Short Communications
Concise reports of preliminary findings, new methods, or hypothesis-generating observations.
Submit your allergy immunology research
IJA welcomes mechanistically rigorous studies that explain how the immune system drives allergic inflammation. There is no charge to submit or to be reviewed; the article-processing charge applies only on acceptance.
Editorial office: [email protected] — for questions about scope fit, submission, or editorial policies.